X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ALEMBIC PHARMA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD ALEMBIC PHARMA ALEMBIC LTD/
ALEMBIC PHARMA
 
P/E (TTM) x 51.3 16.7 307.0% View Chart
P/BV x 2.1 4.5 46.0% View Chart
Dividend Yield % 0.5 0.8 65.2%  

Financials

 ALEMBIC LTD   ALEMBIC PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
ALEMBIC PHARMA
Mar-18
ALEMBIC LTD/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs72645 11.2%   
Low Rs34470 7.2%   
Sales per share (Unadj.) Rs4.7166.1 2.8%  
Earnings per share (Unadj.) Rs6.121.9 27.9%  
Cash flow per share (Unadj.) Rs6.227.5 22.7%  
Dividends per share (Unadj.) Rs0.204.00 5.0%  
Dividend yield (eoy) %0.40.7 52.6%  
Book value per share (Unadj.) Rs40.7117.8 34.5%  
Shares outstanding (eoy) m267.03188.52 141.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.33.4 335.6%   
Avg P/E ratio x8.725.5 34.1%  
P/CF ratio (eoy) x8.520.3 41.8%  
Price / Book Value ratio x1.34.7 27.5%  
Dividend payout %3.318.3 17.9%   
Avg Mkt Cap Rs m14,139105,090 13.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2076,228 3.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,25531,308 4.0%  
Other income Rs m37070 526.6%   
Total revenues Rs m1,62531,378 5.2%   
Gross profit Rs m1116,431 1.7%  
Depreciation Rs m381,055 3.6%   
Interest Rs m234 5.0%   
Profit before tax Rs m4425,413 8.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,212-81 -1,498.1%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m241,204 2.0%   
Profit after tax Rs m1,6304,128 39.5%  
Gross profit margin %8.920.5 43.1%  
Effective tax rate %5.422.2 24.4%   
Net profit margin %129.813.2 984.8%  
BALANCE SHEET DATA
Current assets Rs m1,86718,247 10.2%   
Current liabilities Rs m59111,235 5.3%   
Net working cap to sales %101.622.4 453.8%  
Current ratio x3.21.6 194.4%  
Inventory Days Days9486 110.1%  
Debtors Days Days7461 119.8%  
Net fixed assets Rs m1,79120,035 8.9%   
Share capital Rs m534377 141.7%   
"Free" reserves Rs m10,32421,824 47.3%   
Net worth Rs m10,85822,201 48.9%   
Long term debt Rs m415,000 0.8%   
Total assets Rs m11,59139,411 29.4%  
Interest coverage x260.9160.2 162.9%   
Debt to equity ratio x00.2 1.7%  
Sales to assets ratio x0.10.8 13.6%   
Return on assets %14.110.6 133.3%  
Return on equity %15.018.6 80.7%  
Return on capital %15.219.7 77.0%  
Exports to sales %1.546.4 3.3%   
Imports to sales %21.010.5 199.8%   
Exports (fob) Rs m1914,535 0.1%   
Imports (cif) Rs m2633,288 8.0%   
Fx inflow Rs m1914,722 0.1%   
Fx outflow Rs m2647,026 3.8%   
Net fx Rs m-2447,696 -3.2%   
CASH FLOW
From Operations Rs m2363,124 7.5%  
From Investments Rs m-224-8,844 2.5%  
From Financial Activity Rs m-275,026 -0.5%  
Net Cashflow Rs m-15-693 2.1%  

Share Holding

Indian Promoters % 64.0 74.1 86.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 2.9 6.9%  
FIIs % 9.7 9.1 106.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 13.9 187.8%  
Shareholders   54,701 49,328 110.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   NATCO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  TORRENT PHARMA  STRIDES PHARMA SCIENCE  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Dip After Record Rally; Sensex Ends 298 Points Lower(Closing)

It was a volatile day for Indian share markets today. The BSE Sensex and NSE Nifty opened at record high and went on to touch 40,000 and 12,000.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


May 23, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS